Literature DB >> 6795125

Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.

G L Spitalny.   

Abstract

Macrophages displayed increased spreading, increased Fc-receptor-mediated phagocytosis, and increased secretion of plasminogen activator when collected from the peritoneal cavities of either Listeria-immune mice challenged intraperitoneally 3 days earlier with Listeria or nonimmune mice injected intraperitoneally 3 days earlier with fluid thioglycolate medium. In contrast, macrophages from the thioglycolate-induced peritoneal exudates were severely impaired in vitro in their ability to destroy Listeria. Injection of thioglycolate markedly interfered with the destruction of sublethal intraperitoneal challenge of Listeria, which resulted in nonimmune animals dying of an overwhelming systemic infection. In animals immune to Listeria, injection of thioglycolate delayed the onset of the expression of immunity to an intraperitoneal challenge of bacteria. The thioglycolate-induced suppression of bactericidal activity was determined to be confined to the site of injection. Results of experiments indicated that the colloidal agar in thioglycolate medium was the cause of the impairment of macrophage bactericidal activity. In addition to the impairment of bactericidal activity induced by agar, additional studies showed that an intraperitoneal injection of colloidal agar (0.075% wt/vol) by itself was a sufficient inflammatory stimulus for the accumulation of a large number of host phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795125      PMCID: PMC350853          DOI: 10.1128/iai.34.1.274-284.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.

Authors:  E Wiener; A Bandieri
Journal:  Immunology       Date:  1975-08       Impact factor: 7.397

2.  Biochemical characteristics of activated macrophages.

Authors:  M L Karnovsky; J Lazdins; D Drath; A Harper
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

3.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

Review 4.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

Review 6.  The concept of the activated macrophage.

Authors:  R J North
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Suppression of bactericidal activity of macrophages in ascites tumors.

Authors:  G L Spitalny
Journal:  J Reticuloendothel Soc       Date:  1980-09

8.  Cellular kinetics associated with the development of acquired cellular resistance.

Authors:  R J North
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

9.  The influence of erythrophagocytosis on the interaction of macrophages and salmonella in vitro.

Authors:  F A Gill; D Kaye; E W Hook
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

10.  Trypanosoma cruzi: modification of macrophage function during infection.

Authors:  N Nogueira; S Gordon; Z Cohn
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  12 in total

1.  Posterior vitreous separation and retinal detachment induced by macrophages.

Authors:  Y N Hui; N Sorgente; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages.

Authors:  P C Leijh; T L van Zwet; M N ter Kuile; R van Furth
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

3.  Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli.

Authors:  T S Hamrick; E A Havell; J R Horton; P E Orndorff
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

4.  Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.

Authors:  H Hof; A Christen; J Hacker
Journal:  Infection       Date:  1986 Jul-Aug       Impact factor: 3.553

5.  Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.

Authors:  G I Byrne; C L Faubion
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

6.  Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.

Authors:  M E Agüero; F C Cabello
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

8.  Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.

Authors:  A C Rodloff; J Becker; D K Blanchard; T W Klein; H Hahn; H Friedman
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Time course of antilisterial activity by immunologically activated murine peritoneal macrophages.

Authors:  R W Godfrey; P G Horton; M S Wilder
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

Review 10.  Pathogenic synergy: mixed intra-abdominal infections.

Authors:  D M MacLaren; F Namavar; A M Verweij-Van Vught; W A Vel; J A Kaan
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.